Spots Global Cancer Trial Database for renal insufficiency
Every month we try and update this database with for renal insufficiency cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Risk of Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy | NCT04941625 | Acute Kidney In... | serum cystatin ... serum beta-micr... urine | 20 Years - 75 Years | Chang Gung Memorial Hospital | |
| HaemoDYNAMICs in Primary and Secondary Hypertension | NCT01742702 | Primary Hyperte... Secondary Hyper... Aortic Stenosis Renal Insuffici... | Nitroglycerin 0... Salbutamol 400 ... L-arginine (10 ... Liquorice (2 we... Small milk case... Bisoprolol (5 m... | 18 Years - 99 Years | Tampere University | |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties | NCT00980317 | Kidney Neoplasm... Renal Insuffici... Renal Replaceme... | Restored Kidney... | 20 Years - | Tokushukai Medical Group | |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | NCT04561362 | Advanced Solid ... Urinary Bladder... Triple Negative... Carcinoma, Non-... Ovarian Neoplas... | BT8009 Pembrolizumab | 18 Years - | BicycleTx Limited | |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members | NCT00994188 | Kidney Neoplasm Kidney Stone Ureteral Tumor Ureteral Strict... Renal Insuffici... | Restored Kidney... | 20 Years - | Tokushukai Medical Group | |
| Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency | NCT02045017 | Multiple Myelom... | Pomalidomide an... | 18 Years - | Celgene | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Risk of Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy | NCT04941625 | Acute Kidney In... | serum cystatin ... serum beta-micr... urine | 20 Years - 75 Years | Chang Gung Memorial Hospital | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze | NCT00634504 | Osteosarcoma Leukemia Lymphoma | glucarpidase, h... high-dose metho... | - | BTG International Inc. | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01704079 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin | NCT01599013 | Bladder Transit... | Vinflunine, Gem... Vinflunine, Car... | 18 Years - 79 Years | Pierre Fabre Medicament | |
| BR in Patients With CLL With Comorbidities and/or Renal Dysfunction | NCT01832922 | Chronic Lymphoc... Small Lymphocyt... | Bendamustine Rituximab | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01651000 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin | NCT01599013 | Bladder Transit... | Vinflunine, Gem... Vinflunine, Car... | 18 Years - 79 Years | Pierre Fabre Medicament | |
| A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems | NCT03814005 | Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... Renal Insuffici... Liver Disease Neoplasms | Azacitidine Pevonedistat Docetaxel Paclitaxel Carboplatin | 18 Years - | Takeda | |
| BR in Patients With CLL With Comorbidities and/or Renal Dysfunction | NCT01832922 | Chronic Lymphoc... Small Lymphocyt... | Bendamustine Rituximab | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC | NCT06354231 | Renal Insuffici... Upper Urinary T... Solitary Kidney | DV Toripalimab Laser surgery | 18 Years - | Fudan University | |
| Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality | NCT02668250 | Coronary; Ische... Arrhythmias, Ca... Heart Failure Peripheral Vasc... Dementia Stroke Pulmonary Disea... Respiratory Ins... Alcoholism Cancer Diabetes Renal Insuffici... | OPTI-AGED Usual Care | 75 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) | NCT00792857 | Chronic Kidney ... Secondary Hyper... Chronic Renal I... Chronic Renal F... | CTAP201 Injecti... Doxercalciferol | 18 Years - 80 Years | OPKO Health, Inc. | |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties | NCT00980317 | Kidney Neoplasm... Renal Insuffici... Renal Replaceme... | Restored Kidney... | 20 Years - | Tokushukai Medical Group | |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze | NCT00634504 | Osteosarcoma Leukemia Lymphoma | glucarpidase, h... high-dose metho... | - | BTG International Inc. | |
| Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity | NCT00481559 | Neoplasms | Voraxaze (gluca... | - | BTG International Inc. | |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | NCT04561362 | Advanced Solid ... Urinary Bladder... Triple Negative... Carcinoma, Non-... Ovarian Neoplas... | BT8009 Pembrolizumab | 18 Years - | BicycleTx Limited | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment | NCT02301117 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency | NCT02045017 | Multiple Myelom... | Pomalidomide an... | 18 Years - | Celgene | |
| Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function | NCT00721734 | Multiple Myelom... Renal Insuffici... | Carfilzomib | 18 Years - | Amgen | |
| Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality | NCT02668250 | Coronary; Ische... Arrhythmias, Ca... Heart Failure Peripheral Vasc... Dementia Stroke Pulmonary Disea... Respiratory Ins... Alcoholism Cancer Diabetes Renal Insuffici... | OPTI-AGED Usual Care | 75 Years - | Centre Hospitalier Universitaire de Saint Etienne |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
